New diabetes clinical trial: Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in Individuals With Recent-onset Type 2 Diabetes and Monogenic Diabetes
- Get link
- X
- Other Apps
Published on: August 28, 2020 at 09:30PM
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Dorzagliatin; Drug: placebo
Sponsor: Chinese University of Hong Kong
Not yet recruiting
https://ift.tt/2D5E5VG
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Dorzagliatin; Drug: placebo
Sponsor: Chinese University of Hong Kong
Not yet recruiting
https://ift.tt/2D5E5VG
Comments
Post a Comment